← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Omega Fund Iv, L.P. sold $3.3M of Replimune Group, Inc.

Director and 10% owner

Sold$3,299,009
$32.99Price
100,000Shares
−2%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Thu, Sep 16. Filed Mon, Sep 20, 8:53 AM ET, before the open. Not investment advice.